全身MRI用于预防性健康筛查:管理策略与临床意义
该回顾性研究纳入2009至2020年间576例接受非增强全身MRI筛查的无症状成人,按临床相关性将所见分为4类并对相关者转诊进一步检查。约三分之一参与者有临床相关所见,11.2%接受了由WB-MRI触发的治疗,2.6%发现癌症、4.8%发现颅内动脉瘤,2.8%存在假阴性所见。作者认为WB-MRI可发现大量重要所见并触发治疗干预,但可能不足以检出结肠癌、甲状腺癌和乳腺癌等恶性肿瘤,或可作为健康意识人群的补充筛查方法。
要点
- 约三分之一无症状受检者存在临床相关WB-MRI所见,11.2%接受了由WB-MRI触发的治疗。
- 癌症检出率为2.6%,颅内动脉瘤检出率为4.8%,假阴性率为2.8%(其中5例为癌症)。
- 作者认为WB-MRI可能不足以检出结肠癌、甲状腺癌和乳腺癌,或可作为补充筛查方法。
核心结论
- WB-MRI在大量无症状成人中可发现许多重要所见并触发治疗干预,但鉴于其固有局限性,可能不足以检出结肠癌、甲状腺癌和乳腺癌等恶性肿瘤,或可作为健康意识人群的补充筛查方法。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,回顾2009至2020年间接受WB-MRI的个体,纳入因筛查接受非增强全面WB-MRI的无症状参与者,共576例(男性377例[65.4%]、女性199例[34.6%],平均年龄48.40±10.82岁)。
- 266例(46.2%)使用1.5 T磁体、310例(53.8%)使用3.0 T磁体接受WB-MRI。
- 根据WB-MRI所见将参与者分为4类,具有相关所见(即第3类和第4类)者转诊进一步诊断检查;通过查阅医疗记录和访谈发现假阴性所见并确定由WB-MRI触发的治疗数量。
诊断标准与关键数值
- 采用将WB-MRI所见按临床相关性分类的4类分类系统,具有相关所见(第3类和第4类)者转诊进一步诊断检查。
- 576例中约三分之一显示临床相关所见,65例(11.2%)接受了由WB-MRI触发的治疗。
- 15例(2.6%)发现癌症,28例(4.8%)发现颅内动脉瘤。
- 576例中16例(2.8%)存在假阴性所见,其中5例为癌症。
临床应用与阅片要点
- 作者认为WB-MRI可能不足以检出结肠癌、甲状腺癌和乳腺癌等恶性肿瘤,或可作为健康意识人群的补充筛查方法。
局限性
- 原文述WB-MRI存在固有局限性,可能不足以检出结肠癌、甲状腺癌和乳腺癌等恶性肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To document the diagnostic yields of whole-body MRI (WB-MRI) screening for asymptomatic individuals by using a classification system that categorizes the findings by clinical relevance and provides a flowchart for further investigations, and to determine the influence of WB-MRI findings on clinical decision-making.
METHODS: In this institutional review board-approved study, a retrospective review of individuals who underwent WB-MRI between 2009 and 2020 was conducted, and asymptomatic participants who underwent non-contrast-enhanced comprehensive WB-MRI for screening were enrolled. Participants were classified into four categories based on WB-MRI findings, and those with relevant findings (i.e., categories 3 and 4) were referred for further diagnostic workup. The participants' medical records were investigated, and interviews were conducted to reveal false-negative findings and identify the number of WB-MRI-triggered treatments.
RESULTS: We included 576 participants (377 [65.4 %] men, 199 [34.6 %] women; mean age, 48.40 ± 10.82 years), of which 266 (46.2 %) and 310 (53.8 %) underwent WB-MRI with 1.5 T and 3.0 T magnets, respectively. Approximately one-third of the participants showed clinically relevant findings, and 65 (11.2 %) received a treatment triggered by WB-MRI. Notably, 15 (2.6 %) and 28 (4.8 %) participants had cancers and intracranial aneurysms, respectively. Of the 576 participants, 16 (2.8 %) had false-negative findings, among which five had cancers.
CONCLUSION: WB-MRI yields numerous important findings that trigger therapeutic interventions in a large sample of asymptomatic adults. However, considering its inherent limitations, WB-MRI might be inadequate for detecting malignancies such as colon, thyroid, and breast cancers; thus, it may serve as a complementary screening method for health-conscious individuals.
引用
- Basar Y, Alis D, Tekcan Sanli DE, et al. Whole-body MRI for preventive health screening: Management strategies and clinical implications. Eur J Radiol. 2021. PMID: 33596499. doi:10.1016/j.ejrad.2021.109584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。